Last $5.18 USD
Change Today 0.00 / 0.00%
Volume 2.1K
As of 9:30 AM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robert P. Gasparini M.S. CLSp(CG) CLDir

Chief Scientific Officer, Neogenomics Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

59$336,467
As of Fiscal Year 2013

Background*

Mr. Robert P. Gasparini, also known as Bob, M.S., CLSp(CG), CLDir has been the Chief Scientific Officer of Neogenomics Laboratories, Inc., since January 3, 2005 and served as its President from January 3, 2005 to May 2011. Mr. Gasparini served as the Principal Executive Officer of Neogenomics Inc., until March 16, 2009 and served as its Consultant since May 2004. Prior to NeoGenomics, he was the Director of the Genetics Division for US Pathology Labs, Inc. from January ...

Read Full Background

Corporate Headquarters*

12701 Common Wealth Drive
Fort Myers, Florida 33913

United States

Phone: 239-768-0600
Fax: 239-690-4237

Board Members Memberships*

2005-N/A
Chief Scientific Officer
2005-N/A
Chief Scientific Officer

Education*

BS
University of Connecticut
MS
Quinnipiac University
Master's Degree
Quinnipiac University

Other Affiliations*

Annual Compensation*

Salary$286,603
Bonus$45,000
Total Annual Compensation$331,603

Stock Options*

Exercisable Options1,259,000
Total Number of Options1,734,000

Total Compensation*

Total Annual Cash Compensation$336,467
Total Short Term Compensation$331,603
Total Calculated Compensation$336,467
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NEO:US $5.18 USD 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Marc D. Grodman M.D.Founder, Chairman, Chief Executive Officer, President and Managing Director
Bio-Reference Laboratories Inc.
$1.2M
Kenneth A. Berlin Chief Executive Officer and President
Rosetta Genomics, Ltd.
--
Kimberly J. Popovits Chairman of the Board, Chief Executive Officer, President and Member of Non-Management Stock Option Committee
Genomic Health Inc.
$600.0K
Thomas A. Bologna Chairman and Chief Executive Officer
Response Genetics, Inc
$900.3K
Michael J. Pellini M.D., MBAChief Executive Officer, President and Director
Foundation Medicine, Inc.
$403.9K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEOGENOMICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.